Effect of propranolol on sympathetic nervous activity in hydrallazine-treated hypertensive patients. 1978

M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti

1 The effect of propranolol was examined on a) blood pressure and heart rate responses due to i.v. hydrallazine b) modification of these cardiovascular parameters during cold pressor test c) urinary catecholamine excretion rate. 2 Intravenous hydrallazine reduced significantly mean blood pressure by 15.2 mm Hg and increased heart rate by 24.9 beats/min. Propranolol reduced significantly mean blood pressure by 19.0 mm Hg and heart rate by 14.1 beats/min. Hydrallazine plus propranolol caused a significant reduction of mean blood pressure (by 37.7 mm Hg) but this was not accompanied by a significant fall in heart rate (by 3.3 beats/min). 3 During the control period, cold pressor test increased mean blood pressure by 16.0 mm Hg. Heart rate was increased by 12.5 beats/min in four patients. However, there was a reduction in heart rate (5.5 beats/min) in two other patients. During the propranolol period, cold pressor test-induced increase of mean blood pressure was not reduced but propranolol blocked the increase of heart rate. 4 Urinary catecholamine excretion rate was increased during hydrallazine administration. This excretion was not modified by propranolol.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006830 Hydralazine A direct-acting vasodilator that is used as an antihypertensive agent. Hydrallazin,Apresoline,Apressin,Apressoline,Hydralazine Hydrochloride,Hydralazine mono-Hydrochloride,Hydrazinophthalazine,Nepresol,Hydralazine mono Hydrochloride,Hydrochloride, Hydralazine,mono-Hydrochloride, Hydralazine

Related Publications

M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
January 1981, European journal of clinical pharmacology,
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
July 1975, Nature,
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
January 1981, Nephrologie,
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
January 1975, Japanese heart journal,
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
December 1977, The American journal of psychiatry,
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
January 2021, Journal of clinical hypertension (Greenwich, Conn.),
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
January 1983, International journal of clinical pharmacology research,
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
February 1969, Archives internationales de pharmacodynamie et de therapie,
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
January 2004, Journal of cardiovascular pharmacology,
M Velasco, and E Romero, and H Bertoncini, and A Urbina-Quintana, and J Guevara, and O Hernández-Pieretti
January 1992, American journal of nephrology,
Copied contents to your clipboard!